Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Controlled Release

• Publication date

  2007-02-26

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/J.JCONREL.2006.11.011PMID 17239469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs.

  2006cited by this paper
• Qualitative prediction of solubilization of highly hydrophobic drugs in block copolymer micelles.

  2005cited by this paper
• Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms

  2004cited by this paper
• Unit Operations of Chemical Engineering

  2004cited by this paper
• Analytical derivation of time required for dissolution of monodisperse drug particles.

  2004cited by this paper
• A mechanistic study of danazol dissolution in ionic surfactant solutions.

  2003cited by this paper
• Transport mechanisms in the micellar solubilization of alkanes in oil-in-water emulsions

  2003cited by this paper
• Poor aqueous solubility-an industry wide problem in drug discovery

  2002cited by this paper
• Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7.

  2002cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• General solution for diffusion-controlled dissolution of spherical particles. 1. Theory.

  1999cited by this paper
• Unconventional dissolution methodologies.

  1999cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

  1997cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper
• Dissolution mechanisms of poorly soluble compounds in simple and mixed micelle systems.

  1993cited by this paper
• Solubilization and Wetting Effects of Bile Salts on the Dissolution of Steroids

  1991cited by this paper
• Dissolution, Bioavailability and Bioequivalence

  1990cited by this paper
• Latex particle size distribution from turbidimetry using inversion techniques

  1989cited by this paper
• The mechanism of solubilization in detergent solutions

  1981cited by this paper
• Linoleic acid solubilization with a spinning liquid disc

  1981cited by this paper
• Explaining solubilization kinetics

  1976cited by this paper
• The Scattering of Light and Other Electromagnetic Radiation ~Academic

  1969cited by this paper
• Diffusional Models Useful in Biopharmaceutics: Drug Release Rate Processes

  1967cited by this paper
• DISSOLUTION RATES.

  1965cited by this paper

• A short history of drug nanocrystals – methods, milestones and meaning in pharmaceutical technology

  2024cites this paper
• Significant Progress in Improving Atorvastatin Dissolution Rate: Physicochemical Characterization and Stability Assessment of Self-Dispersible Atorvastatin/Tween 80® Nanocrystals Formulated through Wet Milling and Freeze-Drying.

  2023cites this paper
• Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence

  2022cites this paper
• Application of micellar casein concentrate in 3D-printed food structures

  2022cites this paper
• A comprehensive revision on the nanocarrier drug delivery systems with special reference to artificial intelligence

  2022cites this paper
• Nanopharmacokinetics assessment

  2021cites this paper
• Progress in the development of stabilization strategies for nanocrystal preparations

  2020cites this paper
• Conversion of indomethacin nanosuspensions into solid dosage forms via fluid bed granulation and compaction.

  2020cites this paper
• Relationship between the Ionization Degree and the Inter-Polymeric Aggregation of the Poly(maleic acid-alt-octadecene) Salts Regarding Time

  2020cites this paper
• State of the Art of Pharmaceutical Solid Forms: from Crystal Property Issues to Nanocrystals Formulation

  2019cites this paper
• DRUG DELIVERY: AN OVERVIEW

  2018cites this paper
• Incomplete Loading of Sodium Lauryl Sulfate and Fasted State Simulated Intestinal Fluid Micelles Within the Diffusion Layers of Dispersed Drug Particles During Dissolution.

  2018cites this paper
• An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems

  2018cites this paper
• Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small

  2018cites this paper
• A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs

  2018cites this paper
• Chapter 10 Dissolution of Nanoparticle Drug Formulations

  2017cites this paper
• High drug-loading nanomedicines: progress, current status, and prospects

  2017cites this paper
• Use of Apparatus 4 in Dissolution Testing, Including Sparingly and Poorly Soluble Drugs

  2017cites this paper
• Theoretical Analysis of Drug Dissolution in Micellar Media.

  2017cites this paper
• Physical–chemical properties of furosemide nanocrystals developed using rotation revolution mixer

  2016cites this paper
• Chronotherapeutically Modulated Pulsatile System of Valsartan Nanocrystals—an In Vitro and In Vivo Evaluation

  2016cites this paper
• Methods of Nanonization of Drugs for Enhancing their Dissolution

  2016cites this paper
• IN VITRO RELEASE KINETICS MODEL FITTING OF LIPOSOMES: AN INSIGHT.

  2016cites this paper
• Influence of spray drying and dispersing agent on surface and dissolution properties of griseofulvin micro and nanocrystals

  2016cites this paper
• Menetelmiä nanokiteiden liukenemisnopeuden tutkimiseksi

  2016cites this paper
• State of the art of nanocrystals technology for delivery of poorly soluble drugs

  2016cites this paper
• Nanonized itraconazole powders for extemporary oral suspensions: Role of formulation components studied by a mixture design.

  2016cites this paper
• Enhancement of Rosuvastatin Calcium Bioavailability Applying Nanocrystal Technology and in-vitro, in-vivo evaluations.

  2015cites this paper
• Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy

  2015cites this paper
• Impact of nanosizing on solubility and dissolution rate of poorly soluble pharmaceuticals.

  2015cites this paper
• Analytical technologies for real‐time drug dissolution and precipitation testing on a small scale

  2015cites this paper
• Nanosizing: “End-to-End” Formulation Strategy for Poorly Water-Soluble Molecules

  2015cites this paper
• A Review of In Vitro Drug Release Test Methods for Nano-Sized Dosage Forms

  2014cites this paper
• Drug Delivery and Release From Polymeric Nanomaterials

  2014cites this paper
• Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation.

  2014cites this paper
• Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.

  2013cites this paper
• Dissolution Studies of Poorly Soluble Drug Nanosuspensions in Non-sink Conditions

  2013cites this paper
• Nano-sized crystalline drug production by milling technology.

  2013cites this paper
• Nanocrystal formulation for poorly soluble drugs

  2013cites this paper
• Drug nanocrystals in the commercial pharmaceutical development process.

  2013cites this paper
• The Impact of Solubility and Dissolution Assessment on Formulation Strategy and Implications for Oral Drug Disposition

  2012cites this paper
• Development of a New Method to Assess Nanocrystal Dissolution Based on Light Scattering

  2012cites this paper
• Respirable Low-Density Microparticles Formed In Situ from Aerosolized Brittle Matrices

  2012cites this paper
• Analytical methods for dissolution testing of nanosized drugs

  2012cites this paper
• Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability

  2012cites this paper
• AN UPDATED REVIEW ON TECHNICAL ADVANCES TO ENHANCE DISSOLUTION RATE OF HY DROPHOBIC DRUGS

  2012cites this paper
• Oral nanocrystal formulations and their biopharmaceutical characterization

  2012cites this paper
• Nanosuspensions in Ocular Drug Delivery Systems

  2012cites this paper
• Study of the parameters influencing the co-grinding process for the production of meloxicam nanoparticles

  2011cites this paper
• An automatic method for the determination of saturation curve and metastable zone width of lysine monohydrochloride

  2011cites this paper
• Folate-targeted drug-delivery systems prepared by nano-comminution

  2011cites this paper
• Nanocrystal Technology For Oral Delivery of Poorly Water-Soluble Drugs

  2011cites this paper
• Mechanistic modelling and mechanistic monitoring: simulation and shadowgraph imaging of particulate dissolution in the flow-through apparatus.

  2011cites this paper
• Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.

  2011cites this paper
• An optical method for continuous monitoring of the dissolution rate of pharmaceutical powders.

  2010cites this paper
• Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.

  2010cites this paper
• Diffusion-limited adsorption to a spherical geometry: the impact of curvature and competitive time scales.

  2010cites this paper
• Solid Nanosuspensions: The Emerging Technology and Pharmaceutical Applications as Nanomedicine

  2010cites this paper
• MICROCRYSTALS: FOR IMPROVEMENT OF SOLUBILITY AND DISSOLUTION RATE OF LAMOTRIGINE

  2010cites this paper
• Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats.

  2010cites this paper
• Nanosuspensions and nanostructured lipid carriers for dermal application

  2009cites this paper
• Drug Loading into and In Vitro Release from Nanosized Drug Delivery Systems

  2009cites this paper
• Novel Biodegradable Polyesters. Synthesis and Application as Drug Carriers for the Preparation of Raloxifene HCl Loaded Nanoparticles

  2009cites this paper
• Formulation and stability of itraconazole and odanacatib nanoparticles: governing physical parameters.

  2009cites this paper
• Improvement in the bioavailability of poorly water-soluble drugs via pulmonary delivery of nanoparticles

  2009cites this paper
• Highly supersaturated solutions from dissolution of amorphous itraconazole microparticles at pH 6.8.

  2009cites this paper
• High-throughput system for determining dissolution kinetics of inclusion bodies.

  2009cites this paper
• Contribution of molecular pathways in the micellar solubilization of monodisperse emulsion droplets.

  2008cites this paper
• In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol.

  2008cites this paper
• Conversion of Nanosuspensions into Dry Powders by Spray Drying: A Case Study

  2008cites this paper
• Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.

  2008cites this paper
• A facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid–base neutralization reactions

  2008cites this paper
• High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.

  2008cites this paper
• Solubility and dissolution profile assessment in drug discovery.

  2007cites this paper